YAMAUCHI FUMITAKE

Profiles

Profiles

• 氏名

  YAMAUCHI FUMITAKE

Affiliation

• Department of Cardiovascular Medicine

Research achievements

Published Papers

Original paper
• Optimal uric acid reduction to improve vascular endothelial function in patients with chronic heart failure complicated by hyperuricemia., Naganuma Jin;Sakuma Masashi;Kitahara Keijiro;Kato Toru;Yokomachi Jun;Yamauchi Fumitake;Inoue Riri;Iida Keitaro;Kohno Yuto;Inoue Koki;Koshiji Nobuo;Abe Shichiro;Toyoda Shigeru;Inoue Teruo; , Hypertension research : official journal of the Japanese Society of Hypertension, 46(3), 688-696, 20 Dec. 2022

  DOI
• Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial., Sakuma Masashi;Toyoda Shigeru;Arikawa Takuo;Koyabu Yota;Kato Toru;Adachi Taichi;Suwa Hideaki;Narita Jun-Ichi;Anraku Koetsu;Ishimura Kimihiko;Yamauchi Fumitake;Sato Yasunori;Inoue Teruo, PloS one, 17(1), e0261445, 25 Jan. 2022

  DOI
• 22, 1379-1386, Jun. 2018

  DOI
• Effect of a cardiac rehabilitation program on exercise oscillatory ventilation in Japanese patients with heart failure., Yamauchi F, Adachi H, Tomono J, Toyoda S, Iwamatsu K, Sakuma M, Nakajima T, Oshima S, Inoue T., Heart Vessels, 31(10), 1659-1668, Oct. 2016

  DOI
• Percutaneous coronary intervention for spontaneous coronary artery dissection under intravascular ultrasound guidance., Kageyama M, Yamauchi F, Masawa T, Nasuno T, Sakuma M, Abe S, Inoue T., Int J Cardiovasc Res, 5, 2, Mar. 2016

  DOI
• 46(1), 21-29, Feb. 2016
• Anti-atherosclerotic effects of eicosapentaenoic acid in patients undergoing percutaneous coronary intervention., Nishida H, Abe S, Tajima E, Saito F, Koyabu Y, Fukuda R, Yamauchi F, Sakuma M, Toyoda S, Kikuchi M, Inoue T., J Clin Physiol, 46(1), 21-29, Feb. 2016